A mid-sized European pharmaceutical company engaged DelveInsight to provide in-depth coverage and analysis of key developments presented during ATS 2022, focusing on emerging assets in the Asthma and COPD space.
The primary goal was to capture and analyze all relevant data related to:
Emerging products and developmental activities
Safety and efficacy findings from clinical trials
Product milestones and future development plans
Strategic insights from Key Opinion Leaders (KOLs) and other stakeholders
Stay informed on emerging Respiratory Therapy trends with DelveInsight’s expert conference coverage solutions.
DelveInsight developed and executed a structured and targeted conference coverage plan to deliver valuable insights on the client’s drugs of interest within the Asthma and COPD therapeutic area.
Our dedicated team:
Designed a focused coverage framework to track clinical and commercial updates across priority sessions.
Conducted primary research to gather first-hand KOL and stakeholder perspectives on emerging therapies and clinical outcomes.
Identified high-priority sessions and abstracts for detailed live tracking and data interpretation.
Session Prioritization: Sessions were systematically extracted and classified by relevance to the client’s key assets and strategic interests.
Data Capture & Analysis: DelveInsight’s experts captured detailed presentations, focusing on efficacy results, safety updates, and differentiation points across products.
Strategic Alignment: Key Intelligence Topics (KITs) and Key Intelligence Questions (KIQs) were pre-defined and aligned with the client’s business objectives to ensure insights directly supported internal decision-making.
Real-Time Intelligence: Live coverage was supported by post-event analysis to identify emerging competitors, clinical progress, and R&D implications.
Comprehensive Insights: Delivered a structured report summarizing competitive developments, clinical outcomes, and KOL opinions in the Asthma and COPD space.
Proactive Competitor Monitoring: Enabled the client to anticipate and respond effectively to competitor strategies unveiled during ATS 2022.
Strategic Decision Support: Supported senior leadership with timely updates on market and pipeline movements, enabling faster and informed decisions.
Continuous Intelligence Flow: Established a scalable framework for future respiratory conference coverage, ensuring consistent monitoring of evolving trends.
DelveInsight’s tailored conference coverage transforms event data into actionable intelligence to strengthen your market position. Contact us today to discover how our Respiratory Therapy intelligence services can enhance your strategic planning and competitive readiness.
About Us
DelveInsight is a premier market research and consulting firm focused on healthcare, offering high-quality intelligence and analysis to guide strategic decisions. Our expert team, with profound knowledge of life sciences and healthcare, provides tailored research services and insights worldwide. Reach out for reliable, precise, and timely data to maintain a competitive edge.
Contact Us
Kanishk